ID16910A - Asetilena biaril-asetilena biaril sebagai penghambat-penghambat matriks metaloproteasa-matriks metaloproteasa - Google Patents
Asetilena biaril-asetilena biaril sebagai penghambat-penghambat matriks metaloproteasa-matriks metaloproteasaInfo
- Publication number
- ID16910A ID16910A IDP971606A ID971606A ID16910A ID 16910 A ID16910 A ID 16910A ID P971606 A IDP971606 A ID P971606A ID 971606 A ID971606 A ID 971606A ID 16910 A ID16910 A ID 16910A
- Authority
- ID
- Indonesia
- Prior art keywords
- biaril
- metaloproteasa
- asethyles
- acethylenic
- matrixes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64502896A | 1996-05-15 | 1996-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID16910A true ID16910A (id) | 1997-11-20 |
Family
ID=24587368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP971606A ID16910A (id) | 1996-05-15 | 1997-05-14 | Asetilena biaril-asetilena biaril sebagai penghambat-penghambat matriks metaloproteasa-matriks metaloproteasa |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0912496A1 (id) |
| JP (1) | JP3090957B2 (id) |
| CN (1) | CN1139570C (id) |
| AR (1) | AR007097A1 (id) |
| AU (1) | AU710759B2 (id) |
| BR (1) | BR9709077A (id) |
| CA (1) | CA2253796C (id) |
| CO (1) | CO5080759A1 (id) |
| HN (1) | HN1997000088A (id) |
| HR (1) | HRP970245B1 (id) |
| ID (1) | ID16910A (id) |
| PA (1) | PA8429301A1 (id) |
| SV (1) | SV1997000035A (id) |
| TN (1) | TNSN97084A1 (id) |
| TW (1) | TW381079B (id) |
| WO (1) | WO1997043245A1 (id) |
| YU (1) | YU18697A (id) |
| ZA (1) | ZA974031B (id) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| US6326516B1 (en) | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
| AR035478A1 (es) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene |
| EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
| US8765814B2 (en) | 2010-07-08 | 2014-07-01 | Kaken Pharmaceutical Co., Ltd. | N-hydroxyformamide derivative and medicament containing same |
| CN106458938A (zh) | 2014-04-03 | 2017-02-22 | 拜耳制药股份公司 | 手性2,5‑二取代的环戊烷甲酸衍生物及其用途 |
| US20170114049A1 (en) | 2014-04-03 | 2017-04-27 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases |
| WO2015150363A1 (de) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
| DE2112716A1 (de) * | 1971-03-17 | 1972-10-05 | Thomae Gmbh Dr K | Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester |
| FR2378741A1 (fr) | 1977-02-01 | 1978-08-25 | Fabre Sa Pierre | Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| CO5011113A1 (es) | 1996-05-15 | 2001-02-28 | Bayer Corp | Derivados de acido 3-arilbutirico sustituido como inhibidores de la metaloproteasa de matriz y composiciones farmaceuticas que los contienen |
-
1997
- 1997-05-09 CO CO97025172A patent/CO5080759A1/es unknown
- 1997-05-09 ZA ZA9704031A patent/ZA974031B/xx unknown
- 1997-05-09 HR HR970245A patent/HRP970245B1/xx not_active IP Right Cessation
- 1997-05-09 TN TNTNSN97084A patent/TNSN97084A1/fr unknown
- 1997-05-12 AR ARP970101977A patent/AR007097A1/es unknown
- 1997-05-12 SV SV1997000035A patent/SV1997000035A/es unknown
- 1997-05-12 HN HN1997000088A patent/HN1997000088A/es unknown
- 1997-05-12 CN CNB971964564A patent/CN1139570C/zh not_active Expired - Fee Related
- 1997-05-12 YU YU18697A patent/YU18697A/sr unknown
- 1997-05-12 EP EP97923622A patent/EP0912496A1/en not_active Withdrawn
- 1997-05-12 WO PCT/US1997/007921 patent/WO1997043245A1/en not_active Ceased
- 1997-05-12 AU AU29386/97A patent/AU710759B2/en not_active Ceased
- 1997-05-12 TW TW086106283A patent/TW381079B/zh not_active IP Right Cessation
- 1997-05-12 JP JP09540980A patent/JP3090957B2/ja not_active Expired - Fee Related
- 1997-05-12 BR BR9709077A patent/BR9709077A/pt not_active Application Discontinuation
- 1997-05-12 CA CA002253796A patent/CA2253796C/en not_active Expired - Fee Related
- 1997-05-12 PA PA19978429301A patent/PA8429301A1/es unknown
- 1997-05-14 ID IDP971606A patent/ID16910A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA974031B (en) | 1998-02-19 |
| JP3090957B2 (ja) | 2000-09-25 |
| CA2253796A1 (en) | 1997-11-20 |
| CA2253796C (en) | 2003-10-28 |
| SV1997000035A (es) | 1999-01-14 |
| PA8429301A1 (es) | 2000-05-24 |
| JPH11511179A (ja) | 1999-09-28 |
| BR9709077A (pt) | 1999-08-03 |
| AU710759B2 (en) | 1999-09-30 |
| CN1225623A (zh) | 1999-08-11 |
| TNSN97084A1 (fr) | 2005-03-15 |
| TW381079B (en) | 2000-02-01 |
| HN1997000088A (es) | 1997-06-18 |
| WO1997043245A1 (en) | 1997-11-20 |
| AU2938697A (en) | 1997-12-05 |
| YU18697A (en) | 1999-11-22 |
| EP0912496A1 (en) | 1999-05-06 |
| HRP970245B1 (en) | 2002-06-30 |
| CN1139570C (zh) | 2004-02-25 |
| HRP970245A2 (en) | 1998-04-30 |
| AR007097A1 (es) | 1999-10-13 |
| CO5080759A1 (es) | 2001-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE262512T1 (de) | Arylalkanoylpyridazine | |
| ATE208773T1 (de) | Chinoxalindione | |
| ATE353652T1 (de) | Östroprogestatives antikonzeptionsmittel | |
| DE59708449D1 (de) | Substituierte p-trifluormethylphenyluracile | |
| DE59707428D1 (de) | Substituierte 1-methyl-3-benzyluracile | |
| DE59711889D1 (de) | Substituierte pyrazol-3-ylbenzazole | |
| DE59712222D1 (de) | Substituierte phenyluracile | |
| DE59708674D1 (de) | Substituierte 3-phenylpyrazole | |
| UA1360S (uk) | Електронно-лазерний тир | |
| BR9600867A (pt) | Conjunto empacotadora-enfardadora | |
| ATE267568T1 (de) | Epithese | |
| BR7603492U (pt) | Protemilk | |
| BR7601310U (pt) | Microlivro | |
| BR9600914A (pt) | Lipodecantador | |
| BR9603977A (pt) | Fix-ped | |
| BR7601508U (pt) | Cogafa | |
| BR9603698A (pt) | Hidro-escova dorso-lombar | |
| FI965178A0 (fi) | Avdustningsanordning | |
| BR9602174A (pt) | Lecton massoterapeutico | |
| BR7603147U (pt) | Simborgueup | |
| BR7601548U (pt) | Tomadamax | |
| BR7600429U (pt) | Hidrolax | |
| BR7600260U (pt) | Multi-morsa | |
| FI965055A0 (fi) | Skogsavverkningsanordning | |
| BR7602320U (pt) | Supedânea |